The Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Aging (NIA) awarded a $2,326,159.08 Indefinite Delivery Contract (IDC) to the prime contractor QPS Austria GmbH, a for-profit contract research organization. The IDC, which has a period of performance through May 31, 2025, is to provide experimental validation of candidate Alzheimer's disease treatments identified through multi-omics analyses under the NIA's Drug Repurposing for Effective...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, awarded an indefinite-delivery/indefinite-quantity (IDIQ) contract to Duke University's Office of Research Administration Division to support Phase 0 through Phase II clinical trials of investigational products against infectious diseases. The IDIQ contract, valued at up to $346,610,277, has a performance period from January 14, 2022 to January 13, 2032.
Under this IDIQ,...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), awarded a $346.6 million multiple-award Indefinite Delivery Contract (IDC) called the Early Phase Clinical Trial Units (EPCTU) program. This IDC supports Phase 0 through Phase III clinical trials of investigational products against infectious diseases, including small molecules, monoclonal antibodies, vaccines, and other medical countermeasures. The...
This is a multiple award Indefinite Delivery Contract (IDC) awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to provide comprehensive early phase clinical trial services. The $346.6 million contract, titled "Early Phase Clinical Trial Units (EPCTU)", facilitates Phase 0 through Phase II trials of investigational products against infectious diseases over a 10-year ordering period from...
This indefinite delivery contract (IDC) was awarded by the Department of Health and Human Services (HHS) to the Regents of the University of Michigan (the University of Michigan) on September 25, 2008. The contract has a ceiling value of $3,184,946.35 and a period of performance that runs through September 16, 2016. The University of Michigan, a U.S. state government entity and educational institution, is the prime contractor responsible for providing "OTHER ADMINISTRATIVE SUPPORT...
This is a multiple-award Indefinite Delivery Contract (IDC) with a $80,000,000 ceiling value, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to the UK Health Security Agency (formerly Public Health England), a government agency in the United Kingdom. The contract is for the provision of pre-clinical models and services related to infectious disease research and development, including biological...
This indefinite delivery contract (IDC) was awarded by the Indian Health Service (IHS), a civilian federal agency, to the University of Washington as the prime contractor. It is a hybrid contract for fixed-price services to support the IHS Alzheimer's program, with the authority to issue firm-fixed-price (FFP) and labor-hour (LH) task orders.
The contract has a 5-year period of performance from August 2024 to August 2025 and a ceiling value of $11,357,043. It was awarded under a single-award...
This Indefinite Delivery Contract (IDC) was awarded by the National Institute of Child Health and Human Development (NICHD), a component of the U.S. Department of Health and Human Services (HHS), to Brown University, a private Ivy League research university. The $10 million IDC has an ultimate completion date of September 21, 2020 and is for "Human Laboratory Paradigms R&D" services.
Under this IDC, NICHD has issued multiple task orders to Brown University for human laboratory...
This indefinite delivery contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the Ministry of Defence (doing business as D S T L), a U.K. government entity, to provide pre-clinical models of infectious diseases. The $40 million multiple-award contract runs from July 2017 to July 2024 and is part of NIAID's Preclinical Models of Infectious Diseases program.
Under this contract, the Ministry of Defence will conduct research and...
This Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Emory University, a private research university. The contract has a ceiling value of $146,300,000 and a period of performance through July 2031.
The purpose of this IDC is to provide NIAID with the capability to develop, refine, and employ small animal models, non-human primate models, animal...
The University of Exeter was awarded a single-award Indefinite Delivery Contract (IDC) valued at $1,988,692 by the National Institute on Aging, a civilian agency within the U.S. Department of Health and Human Services. The IDC, awarded in February 2024, has a 30-month ordering period and enables the agency to issue task orders for the university to conduct clinical evaluations of an extended controlled release tablet formulation of Phenserine tartrate for use in the treatment of early mild Alzheimer's disease and mild to moderate traumatic brain injury.
Under the first $962,486 task order, the University of Exeter will leverage its expertise in aging research, dementia, and traumatic brain injury to perform a phase 1/2 clinical trial evaluating the pharmacokinetic and pharmacodynamic properties of the investigational drug. This will involve providing clinical services such as brain imaging, cognitive assessments, and collecting blood and other samples from study participants. The objective is to support the National Institute on Aging's mission to better understand and address neurodegenerative conditions through the clinical evaluation of promising therapeutic candidates.